222 related articles for article (PubMed ID: 29760564)
1. Highly elevated soluble Tim-3 levels correlate with increased hepatocellular carcinoma risk and poor survival of hepatocellular carcinoma patients in chronic hepatitis B virus infection.
Li F; Li N; Sang J; Fan X; Deng H; Zhang X; Han Q; Lv Y; Liu Z
Cancer Manag Res; 2018; 10():941-951. PubMed ID: 29760564
[TBL] [Abstract][Full Text] [Related]
2. Increase in Serum Soluble Tim-3 Level Is Related to the Progression of Diseases After Hepatitis Virus Infection.
Chen L; Yu X; Lv C; Dai Y; Wang T; Zheng S; Qin Y; Zhou X; Wang Y; Pei H; Fang H; Huang B
Front Med (Lausanne); 2022; 9():880909. PubMed ID: 35646962
[TBL] [Abstract][Full Text] [Related]
3. Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression.
Clayton KL; Douglas-Vail MB; Nur-ur Rahman AK; Medcalf KE; Xie IY; Chew GM; Tandon R; Lanteri MC; Norris PJ; Deeks SG; Ndhlovu LC; Ostrowski MA
J Virol; 2015 Apr; 89(7):3723-36. PubMed ID: 25609823
[TBL] [Abstract][Full Text] [Related]
4. PRDM1 levels are associated with clinical diseases in chronic HBV infection and survival of patients with HBV-related hepatocellular carcinoma.
Li N; Fan X; Wang X; Deng H; Zhang K; Zhang X; Wang Y; Han Q; Lv Y; Liu Z
Int Immunopharmacol; 2019 Aug; 73():156-162. PubMed ID: 31100710
[TBL] [Abstract][Full Text] [Related]
5. Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis.
Migita K; Nakamura M; Aiba Y; Kozuru H; Abiru S; Komori A; Fujita Y; Temmoku J; Asano T; Sato S; Furuya M; Naganuma A; Yoshizawa K; Shimada M; Ario K; Mannami T; Kohno H; Kaneyoshi T; Komura T; Ohira H; Yatsuhashi H
PLoS One; 2020; 15(12):e0238540. PubMed ID: 33347507
[TBL] [Abstract][Full Text] [Related]
6. Association of T-cell immunoglobulin and mucin domain-containing molecule 3 (Tim-3) polymorphisms with susceptibility and disease progression of HBV infection.
Liao J; Zhang Q; Liao Y; Cai B; Chen J; Li L; Wang L
PLoS One; 2014; 9(5):e98280. PubMed ID: 24867713
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum soluble CD14 levels in chronic HBV infection are significantly associated with HBV-related hepatocellular carcinoma.
Li N; Zhu Q; Yang C; Li F; Zhou Z; Lv Y; Sang J; Han Q; Liu Z
Tumour Biol; 2016 May; 37(5):6607-17. PubMed ID: 26643893
[TBL] [Abstract][Full Text] [Related]
8. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
[TBL] [Abstract][Full Text] [Related]
9. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
[TBL] [Abstract][Full Text] [Related]
10. Circulating CTLA-4 levels and CTLA4 polymorphisms associate with disease condition and progression and hepatocellular carcinoma patients' survival in chronic hepatitis B virus infection.
Wang L; Li N; Fan X; Wang X; Zhang X; Zhang K; Han Q; Lv Y; Liu Z
Int Immunopharmacol; 2020 Mar; 82():106377. PubMed ID: 32163858
[TBL] [Abstract][Full Text] [Related]
11. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
Yang HI; Tseng TC; Liu J; Lee MH; Liu CJ; Su TH; Batrla-Utermann R; Chan HL; Kao JH; Chen CJ
Clin Gastroenterol Hepatol; 2016 Mar; 14(3):461-468.e2. PubMed ID: 26598229
[TBL] [Abstract][Full Text] [Related]
12. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
Chu CM
J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
[TBL] [Abstract][Full Text] [Related]
13. Immune checkpoint proteins PD-1 and TIM-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with HBV-related hepatocellular carcinoma.
Li Z; Li N; Li F; Zhou Z; Sang J; Chen Y; Han Q; Lv Y; Liu Z
Medicine (Baltimore); 2016 Dec; 95(52):e5749. PubMed ID: 28033288
[TBL] [Abstract][Full Text] [Related]
14. TIGIT
Yu L; Liu X; Wang X; Yan F; Wang P; Jiang Y; Du J; Yang Z
Oncoimmunology; 2021; 10(1):1942673. PubMed ID: 34249476
[TBL] [Abstract][Full Text] [Related]
15. IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
Li N; Zhu Q; Li Z; Han Q; Zhang G; Chen J; Lv Y; Xing F; Chen Y; Zeng X; Liu Z
Mol Carcinog; 2014 Jun; 53(6):447-57. PubMed ID: 23280722
[TBL] [Abstract][Full Text] [Related]
16. Circulating soluble programmed death-1 levels may differentiate immune-tolerant phase from other phases and hepatocellular carcinoma from other clinical diseases in chronic hepatitis B virus infection.
Li N; Zhou Z; Li F; Sang J; Han Q; Lv Y; Zhao W; Li C; Liu Z
Oncotarget; 2017 Jul; 8(28):46020-46033. PubMed ID: 28545019
[TBL] [Abstract][Full Text] [Related]
17. Serum secreted frizzled-related protein 5 levels differentially decrease in patients with hepatitis B virus-associated chronic infection and hepatocellular carcinoma.
Peng C; Xiao X; Kang B; He S; Li J
Oncol Lett; 2014 Sep; 8(3):1340-1344. PubMed ID: 25120720
[TBL] [Abstract][Full Text] [Related]
18. [Progressive increase of serum circulating immune complexes and its significance in patients during the progression from chronic hepatitis B to hepatocellular carcinoma].
Du J; Tian P; Chen TY; Wu JX; Wang JB; Wei Y; Wang LM; Liu LG; Ji WS; Qu CF
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):905-10. PubMed ID: 22340099
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus DNA in peripheral blood leukocytes. A comparison between hepatocellular carcinoma and other hepatitis B virus-related chronic liver diseases.
Leung NW; Tam JS; Lau GT; Leung TW; Lau WY; Li AK
Cancer; 1994 Feb; 73(4):1143-8. PubMed ID: 8313316
[TBL] [Abstract][Full Text] [Related]
20. Regulation of HBV-specific CD8(+) T cell-mediated inflammation is diversified in different clinical presentations of HBV infection.
Dinney CM; Zhao LD; Conrad CD; Duker JM; Karas RO; Hu Z; Hamilton MA; Gillis TR; Parker TM; Fan B; Advani AH; Poordad FB; Fauceglia PL; Kirsch KM; Munk PT; Ladanyi MP; Bochner BA; Bekelman JA; Grandori CM; Olson JC; Lechan RD; Abou GM; Goodarzi MA
J Microbiol; 2015 Oct; 53(10):718-24. PubMed ID: 26428923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
